DHP-Derivative and Low Oxygen Tension Effectively Induces Human Adipose Stromal Cell Reprogramming by Jee, Min Ki et al.
DHP-Derivative and Low Oxygen Tension Effectively
Induces Human Adipose Stromal Cell Reprogramming
Min Ki Jee
1, Ji Hoon Kim
2, Yong Man Han
2, Sung Jun Jung
5, Kyung Sun Kang




1Department of Biotechnology, College of Veterinary Medicine, Seoul National University, Seoul, Korea, 2Department of Biological Sciences, Korea Advanced Institute of
Science and Technology (KAIST), Daejeon, Korea, 3Department of Veterinary Public Health, Laboratory of Stem Cell and Tumor Biology, College of Veterinary Medicine,
Seoul National University, Seoul, Korea, 4Department of Physiology, College of Medicine, Yonsei University, Seoul, Korea, 5Department of Physiology, College of
Medicine, Han Yang University, Seoul, Korea
Abstract
Background and Methods: In this study, we utilized a combination of low oxygen tension and a novel anti-oxidant, 4-(3,4-
dihydroxy-phenyl)-derivative (DHP-d) to directly induce adipose tissue stromal cells (ATSC) to de-differentiate into more
primitive stem cells. De-differentiated ATSCs was overexpress stemness genes, Rex-1, Oct-4, Sox-2, and Nanog. Additionally,
demethylation of the regulatory regions of Rex-1, stemnesses, and HIF1a and scavenging of reactive oxygen species were
finally resulted in an improved stem cell behavior of de-differentiate ATSC (de-ATSC). Proliferation activity of ATSCs after
dedifferentiation was induced by REX1, Oct4, and JAK/STAT3 directly or indirectly. De-ATSCs showed increased migration
activity that mediated by P38/JUNK and ERK phosphorylation. Moreover, regenerative efficacy of de-ATSC engrafted spinal
cord-injured rats and chemical-induced diabetes animals were significantly restored their functions.
Conclusions/Significance: Our stem cell remodeling system may provide a good model which would provide insight into
the molecular mechanisms underlying ATSC proliferation and transdifferentiation. Also, these multipotent stem cells can be
harvested may provide us with a valuable reservoir of primitive and autologous stem cells for use in a broad spectrum of
regenerative cell-based disease therapy.
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Introduction
Although the classic definition of cell plasticity from stem cell
biology specifies the ability of stem cells to differentiate into a
variety of cell lineages, the term is also currently applied to the
ability of a given cell type to reciprocally dedifferentiate, re-
differentiate, and/or trans-differentiate in response to specific
stimuli [1,2]. Cellular de-differentiation underlies contemporary
topical issues in stem cell biology, most notably regeneration and
nuclear cloning. In stem cell biology, this process characterizes the
transition of differentiated somatic cells to pluripotent stem cells,
and is accompanied by global chromatin reorganization, which is
itself associated with the reprogramming of gene expression. De-
differentiation signifies the withdrawal of cells from a given
differentiated state into a stem cell-like state, which confers
pluripotency, a process that precedes re-entry into the cell cycle
[3]. The state of de-differentiation can be determined by changes
in cell morphology, genome organization, and the gene expression
pattern, as well as by the capability of protoplasts to differentiate
into multiple types of cells, depending on the type of applied
stimulus [4–7]. Histone methylation activity is required for the
establishment and maintenance of the de-differentiated state and/
or re-entry into the cell cycle. The complexity of cellular de-
differentiation, and particularly the occurrence of DNA recombi-
nation, can result in genome instability [8]. Several studies have
demonstrated that freezing-induced and traumatic CNS-induced
injuries facilitate the appearance of some radial glia-like fibers,
which express Nestin in adult rodents [9–14]. A variety of
transitional forms of cells are observed during transformation from
radial glia to astroglia in vivo [15–17]. These experimental results
provide a simple means for the acquisition of sizeable quantities of
immature stem cells from the de-differentiation of mature cells.
Stem and/or precursor cells exist within a distinct tissue structure
referred to as the niche, which regulates their self-renewal and
differentiation [18,19]. As recently demonstrated, the bone
marrow microenvironment has a lower oxygen concentration
than other tissues, and stem cells are localized within the hypoxic
regions [20], thereby indicating that hypoxia may be crucial for
the maintenance of stem cells. Under hypoxic conditions, the
differentiation of embryonic stem cells, as well as precursor cells, is
inhibited [21–23]. Conversely, the pro-differentiation gene is also
downregulated as a result of HIF1a activation [24]. In this study,
human adipose tissue stromal cells (ATSC) changed into more
primitive stem cells after exposure to low oxygen and the use of a
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antioxidant, 4-(3,4-dihydroxy-phenyl)-derivative (DHP-d), purified
from Phellinus linteus, a powerful ROS scavenger that induces de-
aging, can induce cell de-differentiation via increases in the
potential for proliferation and differentiation of adult stem cells or
ATSC. On the basis of these findings, we propose that a combined
hypoxia/DHP-d system may improve an essential function in the
maintenance of stem and/or precursor cells. We determined that
differentiated adipocytes with proliferation potential can be
compelled to de-differentiate. Recent observations have demon-
strated that adult somatic stem cells have the capacity to
participate in the regeneration of different tissues [25,26], thereby
suggesting that restrictions on differentiation are not completely
irreversible and can be reprogrammed with de-differentiation and
trans-differentiation processes.
In an effort to determine the characteristics of de-differentiation,
we previously developed a well-defined biological system involving
human ATSC with the potential to differentiate into multiple cell
lineages, including neurons with active migration activity [26].
This study indicates that de-differentiation-induced ATSC can
express molecular and biological characteristics distinct from
native ATSC. After the induction of de-differentiation, the lifespan
of the ATSC was increased significantly, and the therapeutic
efficacies were improved in injured spinal cord and diabetes
animals. The improved lifespan and differentiation ability of the
de-differentiated ATSC strongly indicates that de-ATSC represent
a highly useful candidate cell source for tissue regeneration and
engineering for therapeutic approaches.
Results
Hypoxia/DHP-d Exposure in ATSC As Evidenced by
Various De-Differentiation Behaviors via the Expression
of Stemness Genes
During prolonged culture periods in 10% FBS containing a-
MEM medium, the population of control ATSC underwent a
progressive reduction in proliferation potential, and finally
underwent senescence after passage 13–15 (40–50 days in culture)
(Fig. S1). The cell growth attenuation and cell death by senescence
was highly involved in ROS (Reactive oxygen species) generation
after extended passage through activation of apoptotic cell death
signal molecules such as P38 and MAPK [27]. As shown in Fig.
S1, in an experimental hypoxic and DHP-d-induced ROS
scavenging environment, de-ATSC grew continuously for more
than 3 months (.20 passages) and their cell cycle controlling
factors such as CDK1, CDK2, and RUNX3 expression was
prominently increased along with active growth activity compared
to in the case of hypoxic or DHP-d single treatment (Fig. S2A).
Moreover, hypoxic and DHP-d-induced de-ATSC showed a 2-
fold increased colony forming unit (CFU) and increased synthetic
DNA and over two-fold increased telomerase activity (Figure 1A,
1B, Fig. S2B). As following our experimental results, DHP-d-
inducing cell proliferation activation phenotype was not derived
from their protective function against hypoxia-mediated apoptotic
cell death at the point of cell senescence (Fig. S2A). During
extended cells subculture, we didn’t identified apoptotic cell death
signal such as Caspase 3, PARP, and Cytochrome C expression or
actiation (Fig. S2A).
The phenotypic characteristics of the de-ATSC showed
significantly increased CD90, CD29, CD44, CD117, and
CD133 surface epitope-harboring populations and also they
appeared gradually increased embryonic stem cells markers, such
as Sox2, SSEA4, and TRA1-80 in the results of FACS and
immunocytochemical analysis (Figure 1C and 1D). Low oxygen/
DHP-d was determined to exert prominent effects on the
overexpression of a variety of proliferation-associated genes,
including RUNX3, CDK2, Cyclin D2, CDK1, and telomere reverse
transcriptase (TERT; Figure 1E). As shown in Figure 1E, after 3
days of in vitro culture, the de-ATSC overexpressed several
stemness genes such as Oct4, sox2, Nanog, and Rex1 with
downregulation of the mature neural marker proteins, GFAP, TuJ,
and MAP2ab. As following western blotting and FACS analysis,
the de-ATSC showed extended cell growth through the activation
of JAK/STAT3 and ERK1/2 and overexpression of c-myc
protein and a high ratio of S phase in cell cycles (Figure 1A). In
one essential test conducted to determine whether low oxygen/
DHP-d induced the expression of early developmental genes in
cultured ATSC, we evaluated the expression of Oct-4 (POU5F1),
Sox-2, Rex-1, MMP2, TERT, Utf1, Dapp5, FGF4, ERas, and Nanog
genes (Figure 1D, Figure 2). Following 6 hours of exposure to low
oxygen/DHP-d, human ATSC expressed Oct-4. Most of the
target genes of Oct4 were also upregulated, including Rex1,
Nanog, and Sox2, in addition to Nestin with downregulation of
mature lineage markers such as MAP2ab and GFAP (Figure 1E).
Our study has also provided some additional observations
regarding nuclear remodeling, including the acetylation and
demethylation of histone H3 (Figure 1E). As following cytogenetic
analysis and single nucleotide polymorphism (SNP) experiment of
de-ATSCs, our de-differentiation techniques did not induce
chromosomal abbreviations (Figure 1F) or point mutations (Fig.
S4). On the other hand, we induced the de-differentiation of fully
differentiated fat and bone cells using a hypoxia/DHP-d system.
As a result, the fully differentiated cells exhibited de-differentiated
stem cell behaviors, including active growth with CDK1, CDK2,
RUNX3, and the upregulation of several stemness genes, Rex1
along with the definitive downregulation of mature differentiation
markers (Figure 1G). The bone and fat cells staining and related
genes expression pattern revealed that hypoxia/DHP-d system
also effectively induces the de-differentiation of fully differentiated,
mature bone and fat cells (Figure 1G) and also hypoxia/DHP-d
induced de-ATSCs showed more effective chondrogenesis and
osteogenesis than those of control ATSCs (Fig. S3B).
Hypoxia/DHP-d Effectively Induced Epigenetic
Reprogramming on the Promoter Regions of Stemness
Genes
The analysis of gene expression levels indicated that ,4% of the
total genes were expressed at greater than 2.2-fold for different
levels in ATSC and de-ATSC, as indicated by the r values
(=0.67). A comparison of the expression of those showed that cell
proliferation-associated genes were profoundly upregulated in de-
ATSC (49%). Common gene expression in ATSC and human
embryonic stem cells (hES cells) (n=408) showed dramatically
increased levels of commonly expressed genes in the de-ATSC and
hES cells (n=19969) including stemness genes such as Oct4, Sox2,
Nanog, Klf4, FGFR, and TERT. Genes associated with growth
involving the signal pathway including JAK/STAT3 were also
prominently activated or overexpressed (Figure 2A, 2B). Further-
more, we determined that chromatin remodeling, epigenetic
reprogramming-related genes, and development related genes
were also overexpressed by .2-fold in de-ATSC (Figure 2C,
Table within Figure 2). In an effort to determine whether
hypoxia/DHP-d conditions were capable of eliciting epigenetic
modifications on exogenous chromatin templates, we evaluated
changes in DNA methylation in the stemness genes promoter
regions. We also conducted a bisulfate sequencing analysis in order
to establish the 59-39 CpG methylation profiles across each test
gene proximal promoter, the proximal enhancer, and the early
hATSCs Reprogramming by DHP
PLoS ONE | www.plosone.org 2 February 2010 | Volume 5 | Issue 2 | e9026Figure 1. Combinational hypoxia/DHP-d induced various de-differentiation behaviors in hATSC cells. (A) The proliferation activity of
cultured hypoxia/DHP-d-induced ATSC. Flow cytometric analysis and measuring colony forming units (CFU). For flow cytometric analysis, cells were
cultured in 100-mm dishes at densities that ensured exponential growth at the time of harvesting. Harvesting and processing protocols were used to
detect DNA via flow cytometry with propidium iodide. The percentages of cells in the G0/G1, S, and G2/M phases of the cell cycle were determined
using a DNA histogram fitting program. Clonogenic cell growth experiments were conducted for the detection of colony forming units (CFU). (B)
Telomerase assay of de-ATSC compared to control ATSC. Telomerase activity was assessed using a modified TRAP assay using synthetic
oligonucleotide, telomerase-specific primer. (C) The expression of surface epitopes changed in de-ATSC. For phenotypic characterization by flow
cytometry, de-differentiated ATSC and cultured ATSC adherent cells were incubated with antibodies. The labeled cells were analyzed with a FACScan
argon laser cytometer. (D) Analysis of stem cells phenotypic change in cultured de-ATSCs through TRA 1-80, SSEA4, and Sox2 expression analysis. (E)
Determination of differential expression of stemness, neural markers, and cell proliferation-associated genes by real time RT-PCR and Western
blotting. (F) Detection and confirmation of the chromosomal normality of cultured de-ATSC via karyotyping analysis. (G) De-differentiation of terminal
differentiated ATSC-derived bone and evaluation of fat and their pluripotencies through differentiated fat and bone staining and related gene
expression analysis. Datas presented are presented as mean 6SD; n.3. * p % 0.05 and ** p % 0.01, Student’s t test.
doi:10.1371/journal.pone.0009026.g001
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PLoS ONE | www.plosone.org 3 February 2010 | Volume 5 | Issue 2 | e9026Figure 2. Functional categorization of differentially expressed gene profile and epigenetic reprogramming of stemness genes in
de-ATSC. (A) Functional categorization of genes in de-ATSC. (B) Commonly expressed genes between the de-ATSC and hESC. Also, many kinds of
histones and DNA methylation-related transcription factors and enzymes are overexpressed after ATSC de-differentiation (Table). (C) Differential
embryonic genes, Utf1, Dapp5, FGF4, and Eras expressions in de-ATSCs. (D) Evaluation of epigenetic modifications through methylation analysis on
promoter regions through bisulfite modification and sequencing of genomic DNA. The related method was explained in Materials and Methods S1.
doi:10.1371/journal.pone.0009026.g002
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were assessed, collectively converting the potentially methylated
CpG dinucleotides within nucleotides -869 to +7889 relative to the
TSS (Figure 2D). Seven regions were also analyzed in the Oct4
promoter, encompassing the CpGs within nucleotides -2995 to
+240 relative to the TSS (Figure 2D). The proximal Sox2 region
and the TSS region assessed did not significantly alter the
methylation (Figure 2D). The Rex1 region assessed was highly
methylated in the ATSCs control and was meaningfully
demethylated in the second region from 70.4 (ATSC) to 36.7%
(de-ATSC) and the 3
rd region from 42.5 to 25% (Figure 2D). This
Oct4 methylation pattern was more or less downregulated in the
de-ATSC (5
th region, 71.4%, 7
th region, 36.5%) as compared to
the control ATSC (5
th region, 68.0%; 7
th region, 30%; Figure 2D).
Low Oxygen/DHP-d-Induced ATSC De-Differentiation
with JAK/STAT3 and MAPKinase Activation and Rex1 and
Oct4 Upregulations
In an effort to identify the possible activated signaling molecules
involved in active cell proliferation following hypoxia/DHP-d
exposure, the total protein levels and phosphorylation status of
ERK 1/2 was assessed in the hypoxia/DHP-d exposed ATSC.
ERK1/2 phosphorylation was clearly upregulated 3 hours
(P,=0.05) after hypoxia/DHP-d exposure. The phosphorylation
status reached the maximum at 3 hours and then was reduced to
an undetectable level at the subsequent time points (Figure 3A).
Coincident with the hypoxia/DHP-d-induced ATSC prolifera-
tion, phosphorylated Akt was activated weakly in the de-ATSC and
was markedly increased 6 hours after exposure to a hypoxic
environment (Figure 3A, 3B). Further, de-ATSC proliferation was
also mediated by JAK/STAT3 phosphorylation along with Rex-1,
CDK1, CDK2, and RUNX3 expression (Figure 3B). When
treated with JAKinase inhibitors, STAT3 phosphorylation and
associated proliferation factors involving cell growth and CDK1,
CDK2, Rex1, Nanog, and RUNX3 expression was decreased
profoundly (Figure 3A and 3B, 3C). As is shown in Figure 3A, the
phosphorylated Akt was significantly upregulated after 6 hours of
exposure to low oxygen/DHP-d. Hypoxia/DHP-d-induced
ATSC prominently activated PI3K, GSK3b, MEK, MEKK,
and raf proteins during cell proliferation, and also induced a
profound reduction in ERK1/2 and p38 activation and CDKs,
Rex-1, and Sox-2 downregulation following treatment with
specific inhibitors. (Figure 3A, 3B). The activation of ERK1/2
and Akt in de-ATSC via hypoxia/DHP-d resulted in the induction
of stemness transcription factor expression, and in particular, Rex1
expression (Figure 3A). For further study of the roles of Rex1 in
the proliferation of de-ATSC, the ATSC were transfected with
Rex1 silencing siRNA prior to and after exposure to low oxygen
tension and DHP-d. As is shown in Figure 3C, the Rex1 siRNA
transfected de-ATSC profoundly inhibited cell growth and Rex1
gene expression. The attenuation of cell proliferation by Rex1
inhibition was attended by the downregulation of CDK2, CDK4,
and Cyclin 2 (Figure 3C). Collectively, hypoxia/DHP-d-induced
Rex-1 expression was shown to be positively regulated by JAK/
STAT3 and p38/MEK phosphorylation, and Rex-1 controlling
hypoxia/DHP-d-induced cell proliferation and dedifferentiation
(Figure 3). As following Oct4 knockdown experiment, Oct4 was
also actively involving in cell proliferation and stemnesses genes
expression after dedifferentiation induction (Figure 3D). After
hypoxic stimuli, the expression of HIF1a was induced and their
siRNA transfection resulted in attenuation of hypoxic/DHP-d
activated stem cell growth and related signal protein activation,
including MAPK, JAK/STAT, and AKT (Figure 3E). Also,
HIF1a siRNA transfection prominently induced downregulated
stemness genes expression, such as Rex1, Sox2, Oct4, and Klf4
with prominent growth attenuation (Figure 3E, 3F).
De-Differentiated ATSC Showed p38/JUNK-Mediated
Active Migration and Improved Differentiation Potencies
In Vitro and In Vivo
One of the most important events in wound repair is the
migration of surrounding epithelial cells into the wounded lesion
site. De-ATSC had excellent migration and wound healing
activities against mechanical scratch-induced damage (Figure 4A).
Basically, de-ATSC overexpressing VEGF and PDGFRa function
as paracrine growth factors, and induced active cell migration
prominently involving the phosphorylation of MAPK cascade
proteins, such as p38, ERK1/2, and JUNK (Figure 4). In
particular, the migration of scratched de-ATSC was blocked to
a significant degree by the inhibition of p38 and pERK1/2
phosphorylation by SB203580 and PD98059 (Figure 4B). ATSC
have been identified as progenitors of skeletal tissues, and
differentiate into osteoblast-like cells in cultures supplemented
with ascorbic acid and a glucocorticoid source. ATSC typically
begin to accumulate calcium and lipid droplets following 2–4
weeks of induction in osteogenic and adipogenic differentiation
media. However, de-ATSC was shown to accumulate significant
quantities of calcium and lipid droplets and the differences in the
efficiency of nodule and lipid droplet formation between the naive
and de-ATSC. As is shown in Figure 5A, up to three times as
many lipid droplets and nodules were detected in the de-ATSC as
compared to the control ATSC. After culturing of de-ATSC
(passage 5) in osteogenic differentiation media, we conducted von
Kossa staining for calcium deposits. These results are generally
consistent with what has been observed in conjunction with the
overexpression of adipogenesis- and osteogenesis-related transcrip-
tion factors, including RXR, osteonectin, AP, and PPAR-gamma,
after de-differentiation (Figure 5A). That also appeared highly
enhanced bone and muscle formation by de-ATSC after Alzarin
Red, and Masson staining of the implant tissue sections from de-
ATSC engrafted SCID mice (Figure 5B). Specifically, collagen IV
was highly expressed in the de-ATSC engrafted in SCID mice
(Figure 5B). Moreover, five weeks after the transplantation of de-
ATSC in SCID mice, the results of the hematoxylin-eosin, three
germ layer-derived several organs were generated inside of small
teratoma (Figure 5C). Compare to control ATSC cells, we
observed extremely upregulated TuJ and MAP2ab and low levels
of Nestin expression in the de-ATSCs after neural differentiation
(Figure 6A). A large population of differentiated de-ATSC showed
morphologic and phenotypic characteristics of astrocytes (GFAP),
and neurons (MAP2ab and NF160 [approximately 45% of the
total population]; Figure 6A). Our western blotting results also
confirmed that more efficient transdifferentiation potency of de-
ATSCs than that of control ATSCs (Figure 6B).
Effected Regenerative Behavior of De-ATSC in Injured Rat
Spinal Cords
In order to determine if de-ATSC have regenerative and
therapeutic effects in an injured spinal cord rat model, we evaluated
motor functions using a modified Basso, Beattie, and Bresnahan
(BBB) hind limb locomotor rating scale. As shown in Figure 5b, all
animals subjected to spinal cord injury (SCI) had extensive deficits
in hind limb function overthe first fewdayspost-injury as compared
to the uninjured animals, suggesting that all animals experienced a
similar degree of SCI. By 3 weeks post-SCI, rats administered the
de-ATSC and the ATSC controlled consistently supported their
weight during planar stepping and had a predominantly rotated
hATSCs Reprogramming by DHP
PLoS ONE | www.plosone.org 5 February 2010 | Volume 5 | Issue 2 | e9026Figure 3. Differential expression of the growth-related signal proteins and Rex-1 involvement in active growth of low oxygen/DHP-
d exposed ATSC. (A, B) The involvement of the JAK/STAT3 and MEK signal protein in active cell growth after de-differentiation of ATSC. For the
confirmation of differentially expressed proteins following the de-ATSC, the cells lysates were subjected to SDS-PAGE analysis and transferred to
nitrocellulose membranes. Optimally diluted antibodies were incubated with the membranes. The relative band intensities were determined using
Quality-one 1-D Analysis software. (C) Prominent inhibition of de-ATSC growth by Rex1 siRNA and (D) Oct4 siRNA. Two complementary hairpin siRNA
template oligonucleotides harboring the 21 nt target sequences of the human Rex1 were employed for transient transfection. Three separate Rex1
siRNAs and scrambled siRNAs with the same nucleotide content were assessed. For the detection of the inhibition of de-ATSC growth, we transfected
Rex1 siRNA into de-ATSC counted dye-exclusive viable cells for 6 days. (E) Functional involvement of HIFs in de-ATSC proliferation, proliferation
controlling signal protein, and stemness genes expression. (F) Schematic flow chart of the low oxygen/DHP-d induced ATSC proliferation signal
pathway involving Rex1, Nanog, p53, p21, and c-myc gene expression and activation in the nucleus. Datas presented are presented as mean 6SD;
n.5. * p % 0.05, and ** p % 0.01, Student’s t test.
doi:10.1371/journal.pone.0009026.g003
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injured animals injected only with matrigel had limited joint
locomotion (Figure 6C). Although functional efficacy was observed
in both of the cell-engrafted SCI rats, the results of behavioral
analysis showed that the locomotor function and regeneration
efficacy of de-ATSC-engrafted SCI rats were restored more
significantly, with higher levels of regenerative activity than those
of control ATSC-engrafted rats (Figure 6D, 6E). A higher
percentage (12.5% [de-ATSC] and 8.5% [ATSC]) of motor neuron
and MBP-positive myelin differentiation (NF160/CM-Dil double
positive) was detected in de-ATSC (2.4 and 3.8% of each engrafted
cells) of neural and MBP-positive myelin differentiation in the lesion
sites of SCI (Figure 6D). Engrafted de-ATSCs appeared improved
transdifferentiation potency into electrophysiological active motor
neuron in lesion site of injured spinal cord (46%; about 7 action
potential-positive cells/15 transdifferentiated de-ATSCs into neu-
ron in lesion) (Figure 6E). In contrast of de-ATSCs, control-ATSCs
never showed action potential carrying, transdifferentiated neuron
in lesion site of spinal cord.
Improved Functional Efficacy of De-ATSCs for Diabetes
Therapy
For evaluate transdifferentiation and regenerative activity of de-
ATSC cell into endodermal lineage of cell, we induce beta cell
differentiation of control and de-ATSCs in vitro and chemical-
induced in vivo diabetes animal model. At result, de-ATSC cell was
prominently trans-differentiated into endoderm-originated beta
cells after induction of differentiation. Differentiated de-ATSC
secreted a considerable amount of insulin. However, insulin
producing cells was very rare in the case of control ATSCs after
differentiation induction (Figure 7A). Immunohistochemical anal-
ysis of insulin-positive cells in pancreatic sections also proved more
effective de-ATSCs treatment of diabetes compare to control
ATSCs, since mass of insulin-producing cells became comparable
to that of healthy controls (Figures 7B). As following tissue
immunohistochemical study, in the case of de-ATSCs engrafted
STZ-treated animals showed almost 67% of damaged islet cells
was recovered and they secreting insulin but control ATSCs
engrafted animal showed more or less low density of islet cells
(32%) was showed insulin secretion (Figure 7A, 7B). Engrafted de-
ATSCs also showed effectively transdifferentiated into insulin
secreting beta cell but we never found beta cell transdifferentiated
ATSCs control cells in vivo diabetes animals (Figure 7C). Insulin-
positive cells did not appear in other organs, such as liver, spleen,
lung, and bone marrow (data not shown). To determine whether
or not de-ATSCs contribute to the repair of pancreatic functions,
we injected de-ATSCs or ATSCs control intravenously into STZ-
treated animals. After injection of cells, blood glucose level of
diabetic animals more rapidly returned to normal levels when they
received de-ATSC than that of control ATSCs on day 6–8
(Figure 7D) and engrafted de-ATSCs cells was efficiently
transdifferentiated into insulin secreting beta cells (Figure 7C).
Therefore, de-ATSCs effectively acted in concert in therapy of
experimentally induced diabetes.
Discussion
The results of several previous experiments have shown that
even completely differentiated cells can de-differentiate into
Figure 4. De-differentiated ATSCs evidenced active cell migration. (A) Migration activity of de-ATSC was evaluated as a percentage of the
spontaneous migration and related functional factors. The migration activity of the dedifferentiated ATSC in vitro, the cells were transferred to culture
dishes containing low serum growth medium. The cultured cells were transferred into transwell membranes (8 mm pore size), coated on both sides
with laminin. In the upper chamber, both of cells were preincubated in a CO2 incubator. For analysis, migrating cells on the lower surface were air-
dried and counterstained with Harris hematoxylin and the numbers of cells on the lower surfaces were assessed. Ten x20 fields per insert were
counted. (B) The migration activity of dedifferentiation of ATSCs was caused by ERK, JUNK, and P38 phosporylations. (C) Proposed molecular
mechanism of cell migration after ATSCs reprogramming by DHP-d/Hypoxia. Datas presented are presented as mean 6SD; n.4. * p % 0.05, and ** p
% 0.01, Student’s t test.
doi:10.1371/journal.pone.0009026.g004
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functions. In our study, de- ATSC overexpressed not only Oct-
4, Sox-2, Nanog, and Rex-1, but also c-Myc for the acquisition of
active self-renewal activity with pluripotency. On the other hand,
de-ATSC exhibited prominent p21 and p53 gene downregulation.
Our results show that ATSC can undergo an increase in
developmental potential following reprogramming via the over-
expression of the embryonic transcription factor, Rex1, Oct4, and
Oct4-dependent Nanog and Sox2. Most notably, de-ATSC
reprogrammed somatic nuclei to express the POU family member
homeodomain transcription factor genes, Oct 4 and Rex 1, via a
process necessitating DNA demethylation. Thus, the components
of pluripotent ATSC cells have the potential to elicit reprogram-
ming events in a somatic genome. The proliferation of de-ATSC is
promoted significantly by exposure to hypoxia/DHP-d with highly
improved pluripotency. The results of these studies indicate that
ATSCs possess their own multipotency to de-differentiate into
more primitive stem cells, with the exception of chromosomal
abnormalities and point mutations. Thus, the exposure of ATSC
to low oxygen/DHP-d may provide a good in vitro model to
explore the mechanisms of re-differentiation from the de-ATSC,
which would provide insight into the molecular mechanisms of
ATSC proliferation. Although, the ERK MAPKs generally
regulate cell growth and differentiation, and the JNK and p38
family MAPKs preferentially mediate stress, there is now an
increasing amount of evidence to suggest that the activation of the
ERK MAPKs can also be stimulated by a variety of stress stimuli,
including low oxygen tension [28,29]. Hypoxia/DHP-d can
activate ERK MAPKs via pathways independent or dependent
[30] of Ras and Raf activation. Our results indicated that hypoxia
and DHP-d can activate MEK and ERK1/2 within a few days of
de-differentiation induction. Such a change was also detected with
respect to Akt activation. This study showed, for the first time, that
low oxygen/DHP-d could induce a reversible change of the ATSC
to a more immature de-differentiated state, via not only the PI3K/
Akt-mediated pathway, but also via JAK/STAT3-mediated
signals. The proliferation-associated molecular signal pathway
with a high level of TERT activity occurring in the de-ATSC and
the pattern of gene expression revealed a reversion toward a more
immature phenotype of the cells. The results provided some
insight into the manner in which gene expression in human ATSC
responds to hypoxia/DHP-d. After de-differentiation induction,
HIF1a expression was increased. HIF1a knockdown induced
stemness gene and growth signature downregulation that revealed
that dedifferentiation induced HIF1a expression with cell growth
and growth controlling stemness gene expression directly or
indirectly [31]. The analysis of the differentially expressed genes
indicated that the upregulated genes triggered by hypoxia/DHP-d
can be clustered into different functional groups. Some genes have
been shown to be responsible for cell growth, VEGF-involving
angiogenesis. And also we never identified cell death-related
signature. These results indicated that hypoxia/DHP-d induced
the activation of ATSC and accelerated migration and prolifer-
ation via de-differentiation processes except apoptotic cell death
stimuli. Among the upregulated genes, cell growth regulatory
genes were often observed (49%), including cyclin E2, replication
factor C, cyclin D1, replication protein A2, and cell division cycle
associated 7. Some are relevant to neurogenesis, migration, and
remodeling of ECM and are involved in the regulation of cellular
responses to ECM, including MMP-2. Our results also indicated
Figure 5. Determination of adipogenic, osteogenic, and muscle differentiation potencies of de-ATSC. In vitro (A) and in vivo
Determination of adipogenic, osteogenic, and muscle differentiation potencies of de-ATSC SCID/NOD mice (B). The transplants were recovered 6
weeks later, stained via Alzarin Red (bone), Masson (muscle, chondrocyte), and Van Gieson (chondrocyte) and collagen IV immunostaining. (C)
Teratoma formation from engrafted de-ATSCs in SCID mouse and development of three germ layer-derived tissue or organ such as muscle, neuron,
pigment cell, and gland in teratoma after subcutaneously implantation in 8-week-old immunodeficient beige mice. The paraffin-embedded sections
were stained via H&E, Alzarin Red (bone), Masson (muscle and chondrocytes), and van Gieson (chondrocytes). Datas presented are presented as mean
6SD; n.4. * p % 0.05, and ** p % 0.01, Student’s t test.
doi:10.1371/journal.pone.0009026.g005
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PLoS ONE | www.plosone.org 8 February 2010 | Volume 5 | Issue 2 | e9026Figure 6. The regenerative potency of de-ATSC and their functional efficacy in spinal cord injury rat model. (A)(B) Evaluation of the
neurogenic potency of de-ATSCs in vitro. Neurospheres were cultured and attached on PDL-laminin double-coated well plates. For analysis of the
neural markers expression, fixed cells were incubated with primary antibodies against anti-TuJ 1 and anti-GFAP and fluorescence conjugated
secondary antibodies sequentially. We then analyzed the cells via fluorescence microscopy. And also we confirmed the neurogenic potency of
differentiated de-ATSC by immunoblotting and their quantitative evaluation. (C) In order to determine whether de-ATSCs evidence a regenerative
effect in vivo, we compared motor function using a modified BBB hind limb locomotor rating scale 10 days after SCI. (D) And also we evaluated
transdifferentiation potency of engrafted cells by immunohistochemical analysis of spinal cord tissue. Detail experimental processes was explained in
Materials and Methods. High efficiency of trans-differentiation ability into the neuron and myelin in lesion site of spinal cord. Rounded, dot circle
showed specific region for immunohistochemical analysis of regenerative activity of de-ATSCs in SCI tissue. Raw data from each experiment were
analyzed via analysis of variance with Fisher’s or t-tests. Scale bars represent 40 mm. (E) Functionally active, transdifferentiated neurons from
engrafted cells was evaluated by recording of their evoked action potential before, immediately after and 30 days after the sciatic axotomy. Bipolar
hooked platinum recording and stimulating electrodes were used to induce and record electrical activity. The evoked action potential in responding
to the stimuli (one ms, 20.0 mV) in the ipsilateral sciatic nerve was recorded. Datas presented are presented as mean 6SD; n.5. * p % 0.05, and ** p
% 0.01, Student’s t test.
doi:10.1371/journal.pone.0009026.g006
hATSCs Reprogramming by DHP
PLoS ONE | www.plosone.org 9 February 2010 | Volume 5 | Issue 2 | e9026Figure 7. Reversion of the hyperglycemic condition and regeneration of beta-pancreatic islets in de-ATSCs-treated type 1 diabetic
mice. (A) Beta cell differentiation potency of de-ATSCs cells. For beta-like cell differentiation, cells were cultured in ‘‘N2 media+NA’’ containing
DMEM/F12. After the induction of differentiation, we conducted immnocytochemistry and western blotting using and insulin and c-peptide
antibodies. (B) Quantitative measurement of secreting insulin from de-ATSCs engrafted type1 diabetic animals (left). For analysis of pancreatic islets
tissue-derived insulin secreting functions after anti-insulin/green fluorescence marked ATSCs control and de-ATSC cells treatment in diabetes animals
(right). Pancreatic islets dissected on day 21 from control and STZ-treated mice were stained with hematoxylin and eosin or (C) immunostained for
mouse insulin. Scale bars =20 mm. White arrows revealed that transdifferentiated and insulin secreting engrafted de-ATSCs. (D) Measurement of
blood glucose concentration before and after each cell (2610
5 cells) engraftment. Pancreatic damage was induced with intraperitoneal injection of
50 mg/kg of body weight STZ daily for five consecutive days. Datas presented are presented as mean 6SD; n.8. Black and blue arrows appear the
date of STZ and cells injection each other. Detail experimental processes was explained in Materials and Methods. Data are represented as mean 6SD;
n.8. * p % 0.05, and ** p % 0.01, Student’s t test.
doi:10.1371/journal.pone.0009026.g007
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those signal molecules effectively induced de-ATSC migration
involving wound healing.
In our study, the low oxygen/DHP-d treatment of ATSC
provides a simple method for the production of primitive stem
cells via ROS controlled de-aging process, and may also be
utilized in the investigation of the mechanisms underlying
differentiation and de-differentiation. Based on the morphologic
and immunocytochemical features observed herein, we showed
that ATSC induced by hypoxia/DHP-d stimuli are de-
differentiated, rejuvenated immature stem cells, and also de-
ATSC have excellent multipotency for endodermal beta cell and
ectodermal neuron differentiation. Specially, de-ATSC has
dramatic regenerative ability in spinal cord injured rats and
diabetes mice with improved motor function. Given the active
growth and differentiation potency induced by the de-differen-
tiation processes of adult stem cells and the relative ease with
which genetically unchanged multipotent stem cells can be
harvested. Finally, our ATSC reprogramming strategy may
provide us with a potentially considerable reservoir of novel
stem cells for use in novel and improved cell-based disease
therapies.
Materials and Methods
Isolation and Culture of Adipose Tissue-Derived Stem
Cells
Donor-derived the raw adipose tissues were processed in
accordance with established methodologies in order to determine
the stem vascular functions [23,24]. Human raw fat tissue
obtained from the patient abdomen (as following patient’s
approval document) was processed according to established
methodologies to determine stem cell vascular function. In order
to isolate the stem cells, the samples were digested with 0.075%
collagenase IV (Sigma) and centrifuged at 12006g for 10 minutes
to acquire a high density cell pellet. The pellet was then suspended
in red blood cell (RBC) lysis buffer (Biowhittaker, Walkersville,
MD, USA) and incubated for 10 minutes at room temperature to
lyse the contaminating RBCs. The stem cell pellet was then
collected and incubated overnight at 37uC/5% CO2 in 10% FBS
containing a-MEM medium (GIBCO BRL, CA, USA). This work
was approved by Seoul National University Institutional Review
Board (IRB No. 0603/001-002-07C1) and the ethics committee
specifically approved that procedure.
ATSC De-Differentiation Induction by Low Oxygen
Tension and DHP-d
Human ATSC were cultured to passage 5–6 (P5-P6). ATSC
were cultured at 37uC in a humidified atmosphere containing 5%
CO2 with a-MEM containing 10% FBS and antibiotics (all
obtained from Gibco BRL). In present study, we also used 4-(3, 4-
Dihydroxy-phenyl) (DHP) derivative purified from phellinus linteus,
a medicinal fungus known as "Sang-hwang" in Korea for cell
reprogramming. For DHP derivative purification from phellinus
linteu, DHP derivative was extracted with ethanol for 1 week. The
ethanol extract was suspended in hexane and H2O. The hexane
extract was subjected to repeated silica gel (0.063–0.200 mm,
Merck) column chromatography, using a hexane-ethyl acetate
gradient as the eluting solvent. High-performance liquid chroma-
tography (YMC-Pack ODS-AM, 25066.0 mm, ID 5 mm; with
acetonitrile 70%, flow rate provided DHP derivative. For hypoxic
stimulation, the culture plates were incubated in the chambers
(Billups-Rothenberg, CA, USA) flushed with a gas mixture
containing 1% O2,5 %C O 2, and 94% N2 at 5–8 psi for 2 or 6
hours in the novel antioxidant (DHP-d [10 ng/ml])-containing
culture medium. The humidified chambers were sealed and
maintained at 37uC, then incubated further. The controls included
parallel cultures in which the cells were exposed to normoxic
conditions (21% oxygen tension). After de-differentiation, de-
ATSC were maintained in a DHP-d (10 ng/ml)-containing
culture medium. The media were initially replaced at 48 hours
and then every fourth day thereafter. Purified and characterized
DHP-d was kindly supplied by Dr. Jeon (Korean Research
Institute of Biological Biotechnology).
Non-Radioisotopic Telomerase Assay
Telomerase activity was assessed using a modified telomeric
repeat amplification protocol (TRAP) assay, in accordance with
the manufacturer’s instructions (BD Science). Protein extracts
were prepared from the ATSC controls and the de-ATSC. Protein
extracts (0.5 mg) prepared from each cell line was incubated in the
presence of synthetic oligonucleotide (telomerase-specific primer,
59-AATCCGTCGAGCAGAG TT-39), which could be the
substrate for the addition of telomeric repeats by telomerase. If
telomerase activity was detected in the extracts, the oligonucleo-
tide was elongated and could function as a template in subsequent
polymerase chain reactions (PCR). PCR was conducted in the
presence of nucleotides, and the formation of the amplification
products was assessed via the monitoring of telomerase repeat
amplification. PCR reaction products were separated on 12.5%
non-denaturing acrylamide gels and stained using Syber-Gold dye
(Molecular Probes, Eugene, OR, USA). Quantification of
telomerase for comparisons with telomerase activity in the de-
ATSC and the ATSC controls was conducted via the PCR
enzyme-linked immunosorbent assay procedure suggested by the
manufacturer (BD Science).
Oligonucleotide Microarray and Data Analysis
Samples for gene array analysis were prepared from the total
RNA, and microarray analysis was conducted in accordance with
the manufacturer’s recommendations. Fragmented cRNA
(15 mg) was hybridized for 16 hours at 45uC to the HG-U95A
array for the comparison study (Affymetrix, Santa Clara, CA,
USA). After hybridization, the probe arrays were scanned at
3 mm resolution using the Genechip System confocal scanner
made for Affymetrix by Agilent. Affymetrix Microarray Suite 4
was used to scan and analyze the relative abundance of each gene
as derived from the average differences in fluorescence intensity.
The output from the microarray analysis was merged with the
Unigene or Genebank descriptor and stored as an Excel
(Microsoft Corp., Redmond, WA, USA) data spreadsheet. The
definition of a 2-fold change, or no change in the expression of
individual genes was predicated on the ranking of the difference
call (DC) from two comparisons (291), namely, no change (NC) of
expression for individual genes was merged with the Unigene or
GeneBank descriptor and stored as an Excel data spreadsheet.
The reproducibility of paired experiments was evaluated on the
basis of the coefficient of variation (CV; SD/mean) for fold
change (FC). The CV of FC must be #1.0. Finally, genes with a
FC .2.0 were considered to be significant. These cut-off values
represented a conservative estimate of the numbers of genes
whose expression levels differed between samples. Gene catego-
rization was based on a literature review. All data is MIAME
compliant and that the raw data has been deposited in a MIAME
compliant database (ArrayExpress, GEO), as detailed on the
MGED Society website http://www.mged.org/Workgroups/
MIAME/miame.html.
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Derived Bone and Fat, and Their Pluripotency
For the de-differentiation of fully differentiated ATSC into bone
and fat, culture was developed at 37uC in a humidified atmosphere
containing 5% CO2 with a-MEM containing 10% FBS and
antibiotics. For de-differentiation, the culture plates were incubat-
ed in the hypoxic chambers and flushed with a gas mixture
containing 1% O2,5 %C O 2, and 94% N2 at 5–8 psi for 2 or 6
hours in DHP-derivative (10 ng/ml) containing culture medium at
37uC. The controls included parallel cultures in which the cells
were exposed to normoxic conditions (21% oxygen tension).
Finally, we verified the pluripotency of the de-differentiated cells
via differential expressions of stemness genes, bone and fat
markers, and cell growth-associated genes and the staining level
of bone and fat after de-differentiation.
Inhibition of De-Differentiated ATSC Cell Growth by Rex1
siRNA
Two complementary hairpin siRNA template oligonucleotides
harboring the 21 nt target sequences of the human Rex1 were
employed for transient transfection with Lipofectamine
TM2000
(Invitrogen) using 50 nM siRNA. Furthermore, the quantity of
siRNA was optimized in accordance with the manufacturer’s
instructions. Three separate Rex1 siRNAs (SilencerH predesigned
siRNAs; Ambion) and scrambled siRNAs with the same nucleotide
content were assessed. When compared with unrelated control
siRNAs and scrambled siRNAs, the Rex1 siRNAs resulted in an 80–
90% reduction in Rex1 mRNA levels, as determined via real-time
PCR. The siRNA that provided the most efficient inhibition (90–95%)
was utilized for the experiments. For the detection of the inhibition of
de-differentiated ATSC growth, we transfected Rex1 siRNA into de-
differentiated ATSC counted dye-exclusive viable cells for 6 days.
Bisulfite Modification and Sequencing of Genomic DNA
Genomic DNA was purified via phenol/chloroform/isoamylalco-
hol extraction, followed by one chloroform extraction, after which
the DNA was ethanol-precipitated. The DNA was dissolved in
distilled water. Bisulfite conversion was conducted using the EZ
DNA Methylation–Gold kit (Zymo Research, USA), as described by
the manufacturer. Briefly, unmethylated cytosines in DNA were
converted into uracil via the heat-denaturation of DNA and with a
specially designed CT conversion reagent. DNA was then desulpho-
nated and subsequently cleaned and eluted. The bisulfite-modified
DNA was then immediately utilized for PCR or stored at or below
220uC. The converted DNA was amplified via polymerase chain
reaction (PCR) or designed with MethPrimer (http://www.urogene.
org/methprimer) (Table S1). The PCR reactions were conducted in
a MyGenie 96 Gradient Thermal Block (Bioneer, Daejeon, South
Korea) in accordance with the following protocol: 95uCf o r1 5m i n ,
40 cycles of 95uC for 20 sec, 43–58uC for 40 sec, 72uCf o r3 0s e c ,
followed by an extension at 72uC for 10 min, and soaking at 4uC.
The PCR productswerecloned into bacteria(DH5a) bya pGEMT-
Easy Vector System I (Promega, Madison, WI, USA). DNA
extracted from bacterial clones was analyzed via sequencing with
the M13 reverse primer (59-AGCGGATAACAATTTCACA-
CAGGA-39), using an ABI 3730XL capillary DNA sequencer
(Applied Biosystems) and represented as rows of circles, with each
circle symbolizing the methylation state of one CpG.
Induction of Rat Spinal Cord Injury and Cell
Transplantation
Adult female Wistar rats weighing 250 g (,5 weeks of age) were
housed in a controlled environment and provided with standard
rodent chow and water. Animal care was carried out in
compliance with Korean regulations regarding the protection of
animals used for experimental and other scientific purposes. The
animals were subjected to traumatic spinal cord injury via a
modified version of the protocol described by Kang et al. [32]. In
brief, the spinous processes of T9 and T10 were removed with
rongeurs, and a laminectomy was performed using a dental drill
and rongeurs to expose the dorsal spinal cord in anesthetized rats.
The dura was incised with microscissors and the dorsal and ventral
columns, including the dorsal and ventral corticospinal tract
(CST), were cut by lowering microscissors attached to a sterotaxic
arm to a depth of 3.5 mm below the dorsal surface of the spinal
cord and cutting twice. Experimental trials were first conducted to
ascertain that this surgical procedure caused a consistent total
transaction of the CST on both sides. For cell transplantation,
GFP-lentivirus-labeled cells (1610
6 cells) were suspended in
HBSS, mixed in accordance with the manufacturer’s instructions
with Matrigel (Gibco-BRL) and directly injected into the lesion site
1 week after injury. The control (vehicle) group received the same
volume of HBSS mixed with Matrigel only. The rats were then
randomly assigned into three groups: 15 spinal cord injury (SCI)
rats receiving cell treatment (ATSC control or de-ATSC each) and
5 SCI rats as controls. A total of 35 animals were utilized in these
experiments.
Evaluation of Trans-Differentiation Properties of De-
Differentiated Cells In Vitro and In Vivo Sci Rat Model
For the induction of neural differentiation, we cultured
neurospheres in a neurobasal medium (NB; Invitrogen, Gai-
thersburg, MD, USA), supplemented with B27 (Invitrogen),
20 ng/ml of bFGF, and 10 ng/ml of EGF (Sigma) for 4–7 days.
The culture density of the spheroid bodies was maintained at 20–
50 cells/cm
2 to prevent self-aggregation. Then, neurospheres
derived from the cells were layered and cultured further on PDL-
laminin double-coated well plates. To determine the expression
of the neural markers, differentiated ATSC were fixed in 4%
paraformaldehyde (PFA) fixative solution for 30 minutes at room
temperature. After extensive washing in PBS, the cells were
blocked for 30 minutes at room temperature with 1% normal
goat serum. The cells were then incubated with primary
antibodies against anti-TuJ 1 (1:500; Sigma) and anti-GFAP
(1:1500; DAKO, USA). After extensive washing, the cells were
incubated with FITC or Texas-Red conjugated secondary
antibodies (1:250; Molecular Probes, USA). We then analyzed
the cells via fluorescence microscopy (Leica Microsystems, PA,
USA). For cell-engrafted spinal cord tissue analysis, we
performed immunohistochemistry as described in Materials
and Methods S1.
Electrophysiological Recording
Electrophysiological evaluation (evoked action potential
of engrafted De-ATSCs) was performed before, immediately
after and 30 days after the sciatic axotomy and De-ATSCs
transplantation. Under anesthesia, the rat’s left sciatic nerve and
fourth digital nerve were exposed. Bipolar hooked platinum
recording and stimulating electrodes were used to induce and
record electrical activity. The stimulating electrode was placed
under the proximal sciatic nerve and the recording electrode was
placed under the fourth digital nerve. The evoked action
potential in responding to the stimuli (one ms, 500 mV) in the
ipsilateral sciatic nerve was recorded using Powerlab-800
system (AD Instruments, Colorado Springs, CO, http://www.
adinstrumentsinc.com).
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Transplantation
Female C57BL6 mice, 8–10 weeks old were injected intraper-
itoneally (i.p.) with 50 mg/kg of body weight STZ (Sigma-Aldrich,
St. Louis, Sigma) daily on five consecutive days. STZ was
solubilized in sodium citrate buffer, pH 4.5, and injected within 15
minutes of preparation. And, control ATSCs (2610
5) and de-
ATSCs (2610
5) were transplanted by tail vein injection on day 15
following STZ induction of diabetes (n=8). Blood glucose was
measured twice weekly with a glucometer (Accu-Chek Active
blood glucose meter; F. Hoffmann-La Roche, Basel, Switzerland).
Those animals were considered diabetic whose blood glucose level
exceeded 10 mM at days 14 and 15. All animal procedures were
approved by the Animal Care and Use Committee of the 21
century Frontier Stem Cells Research Center (South Korea).
Statistical Analysis
All data were expressed as the means 6 S.E.M from five or more
independent experiments. The statistical significance of differences
between groups was calculated via Student’s two tailed t-test.
Supporting Information
Materials and Methods S1 Supplementary materials and
methods.
Found at: doi:10.1371/journal.pone.0009026.s001 (0.06 MB
DOC)
Figure S1 Evaluation of longevity and proliferation activity of
dedifferentiated ATSC cells in long-term extended culture. (A)
Cell proliferation activity was monitored by BrdU immunostaining
at the specific passage of cultured de-ATSCs. (B) Viable cell
counting was conducted via visual cell counts in conjunction with
trypan blue exclusion. Data presented are presented as mean
6SD; n.4. * p% 0.05, and ** p% 0.01, Student’s t test.
Found at: doi:10.1371/journal.pone.0009026.s002 (4.19 MB TIF)
Figure S2 Function of Hypoxia/DHP-d in cell proliferation
activity except apoptotic cell death signals in De-ATSC cells and
TERT activity. (A) Verification of cell growth attenuation and
exclusion of apoptotic cell death following de-ATSCs extended
passage through cell proliferation and apoptotic signature analysis.
(B) Comparative telomerase activities in de-ATSC cells, hES cell,
and brain cancer cell lines, U87MG and A172.
Found at: doi:10.1371/journal.pone.0009026.s003 (5.04 MB TIF)
Figure S3 Effects of Hypoxia/DHP-d exposure time on cell
proliferation and differentiation efficiency of De-ATSCs. (A)
Effects of Hypoxia/DHP-d exposure time schedule on cell
proliferation after cell reprogramming. (B) Chondrogenic and
Adipogenic differentiation efficiency in De-ATSCs compared to
control ATSCs. Data presented are presented as mean 6SD;
n.4. * p% 0.05, and ** p% 0.01, Student’s t test.
Found at: doi:10.1371/journal.pone.0009026.s004 (2.96 MB TIF)
Figure S4 Verification of genetic stability of dedifferentiated
ATSCs through single nucleotide point (SNP) mutation analysis
compared to control ATSCs.
Found at: doi:10.1371/journal.pone.0009026.s005 (3.20 MB
PDF)
Table S1 Bisulfite sequencing primers used in this study.
Found at: doi:10.1371/journal.pone.0009026.s006 (0.07 MB
DOC)
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